Concepedia

John F. DeCoteau

JF

41

Publications

1.8K

Citations

25

H-Index

1987

Active since

Affiliations

University of Saskatchewan(Current)

Royal University Hospital

Harvard University

Saskatchewan Cancer Agency

Beth Israel Deaconess Hospital

John F. DeCoteau is an author at University of Saskatchewan specializing in medicine, cell biology, and tumor biology.

ORCID

Top concepts

Publications per year

1987–2022

41

Publications

41

RecA Inhibitors Potentiate Antibiotic Activity and Block Evolution of Antibiotic Resistance

Md. Kausar Alam, Areej Alhhazmi, John F. DeCoteau et al. · Cell chemical biology · 2016 · 150 citations · Full text

, , +10

A Dominant Inhibitory Mutant of the Type II Transforming Growth Factor β Receptor in the Malignant Progression of a Cutaneous T-Cell Lymphoma

Petra Knaus, Dirk Lindemann, John F. DeCoteau et al. · Molecular and Cellular Biology · 1996 · 143 citations · Full text

, , +16

Reexpression of epigenetically silenced AML tumor suppressor genes by SUV39H1 inhibition

Ashakumary Lakshmikuttyamma, Stuart A. Scott, John F. DeCoteau et al. · Oncogene · 2009 · 108 citations · Full text

Loss of functional cell surface transforming growth factor β (TGF-β) type 1 receptor correlates with insensitivity to TGF-β in chronic lymphocytic leukemia

John F. DeCoteau, Petra Knaus, Haya Yankelev et al. · Proceedings of the National Academy of Sciences · 1997 · 98 citations · Full text

The EphB6 Receptor Cooperates with c-Cbl to Regulate the Behavior of Breast Cancer Cells

Luke Truitt, Tanya Freywald, John F. DeCoteau et al. · Cancer Research · 2010 · 84 citations · Full text

Rows per page

1–5 of 41